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Neural networks that regulate an organism’s internal
environment must sense perturbations, respond
appropriately, and then reset. These adaptations
should be reflected as changes in the efficacy of the
synapses that drive the final output of these homeo-
static networks. Here we show that hemorrhage, an
in vivo challenge to fluid homeostasis, induces LTD
at glutamate synapses onto hypothalamic magnocel-
lular neurosecretory cells (MNCs). LTD requires the
activation of postsynaptic a2-adrenoceptors and the
production of endocannabinoids that act in a retro-
grade fashion to inhibit glutamate release. In addition,
both hemorrhage and noradrenaline downregulate
presynaptic group III mGluRs. This loss of mGluR
function allows high-frequency activity to potentiate
these synapses from their depressed state. These
findings demonstrate that noradrenaline controls
a form of metaplasticity that may underlie the reset-
ting of homeostatic networks following a successful
response to an acute physiological challenge.
INTRODUCTION
The survival of an organism depends upon its ability to quickly,
effectively, and repeatedly defend homeostatic setpoints. This
requires neural networks that regulate autonomic and neuro-
endocrine outputs to possess intrinsic mechanisms that allow
them to respond to a challenge, adapt, and then reset. The
precise nature of these mechanisms remains unresolved. Here
we hypothesized that bidirectional changes in synaptic strength
may be particularly useful in regulating the output of networks
that must make continual adjustments in response to moment-
to-moment changes in physiological input.
While persistent changes in synaptic efficacy, such as long-
term potentiation (LTP) and long-term depression (LTD), are
essential for information storage in neural networks (Malenka
and Bear, 2004), a complementary mechanism, metaplasticity,
maintains network stability and ensures that synapses operate
within a functional dynamic range by modifying the expression
of synaptic plasticity as a function of prior activity (Abraham,
2008). Presynaptic metabotropic glutamate receptors (mGluRs),which regulate the release of neurotransmitter at nerve terminals,
have recently been implicated in a novel form of metaplasticity in
the hippocampus (Pelkey et al., 2005). In this scenario, group III
mGluRs undergo agonist-induced internalization, unmasking
a state permissive for subsequent activity-dependent LTP of
glutamate synapses. Loss of mGluR function has also been re-
ported at glutamatergic synapses onto hypothalamic magnocel-
lular neurosecretory cells (MNCs) in the paraventricular nucleus
of the hypothalamus (PVN) (Gordon and Bains, 2003). These
neurons integrate local and synaptic information regarding blood
volume andmake neuroendocrine adjustments to maintain body
fluid homeostasis (Bourque, 2008; Poulain and Wakerley, 1982).
A precipitous drop in blood volume triggers an immediate
increase in the activity of these cells (Poulain et al., 1977;Wakerly
et al., 1975) that is driven by the release of noradrenaline (NA)
from ascending fibers (Buller et al., 1999). While this causes an
immediate increase in neuronal activity through synaptic actions
that increase quantal glutamate release (Boudaba et al., 2003;
Gordon andBains, 2003) and promote the postsynaptic insertion
of AMPA receptors (Gordon et al., 2005), NA is also the substrate
necessary for the functional inactivation of presynaptic high-
affinity, group III mGluRs (Gordon and Bains, 2003).
Here we asked whether glutamate synapses onto MNCs
adapt following in vivo hemorrhage and then whether these
adaptations would favor an activity-dependent resetting of these
synapses. Using whole-cell patch-clamp recordings fromMNCs
in hypothalamic brain slices, we demonstrate that in vivo hemor-
rhage-induced release of NA in the PVN decreases the proba-
bility of evoked glutamate release onto MNCs. This LTD is
mimicked by bath application of NA to naive slices and is accom-
panied by a complete loss of function of group III mGluRs.
Subsequent high-frequency stimulation (HFS) can cause both
restoration of synaptic strength and a gain of mGluR function.
These observations demonstrate that mGluRs are essential for
metaplastic synaptic changes that may allow networks regu-
lating fluid homeostasis to adapt and reset.
RESULTS
Presynaptic LTD following In Vivo Hemorrhage
To examine synaptic changes responsible for restoring body
fluid volume homeostasis, we assessed synaptic efficacy in
hypothalamic slices obtained from rats that had been subjected
to a hypovolemic hemorrhage (removal of 25% blood volume),
a stimulus that strongly activates MNCs in the PVN of theNeuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc. 839
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et al., 1975). Brain slices containing the PVN were prepared
30 min after the hemorrhage to allow a sustained period of
noradrenergic drive and increased neuronal activity. Glutamater-
gic synaptic transmission was examined in acute rat hypotha-
lamic slices by recording from visually and electrophysiologically
identified (Luther and Tasker, 2000) MNCs in the PVN. In
comparison to control slices, evoked excitatory postsynaptic
currents (eEPSCs) recorded from hemorrhaged rats displayed
a lower probability of glutamate release (Pr) as indicated by a
significantly enhanced paired-pulse ratio (PPR; EPSC2/EPSC1:
control 1.51 ± 0.07; n = 57; hemorrhage 1.95 ± 0.19; n = 15;
p = 0.009), more synaptic failures (failure rate, failures/30 events:
control 0.04 ± 0.01; hemorrhage 0.15 ± 0.04; p = 0.0004), and an
increase in the coefficient of variation (CV; standard deviation/
mean; control 0.39 ± 0.02; hemorrhage 0.50 ± 0.04; p = 0.02;
Figures 1A and 1B). Thesemeasures of reduced synaptic release
efficacy persisted for at least 4.5 hr after slicing. No significant
changes in PPR were noted if brain slices were prepared imme-
diately (2 min) following the hemorrhage (control 1.51 ± 0.07; n =
57; 2min hemorrhage 1.35 ± 0.13; n = 18; p = 0.28). These obser-
vations indicate that glutamate synapses onto MNCs exhibit
a presynaptic LTD following hemorrhage.
Figure 1. Hemorrhage Lowers Pr at Glutamate Synapses
(A) eEPSCs in slices obtained from hemorrhaged rats (blue) dis-
played an increased PPR when compared with controls (black).
Current traces are averages of 30 consecutive responses from
each condition. For paired-pulse recordings, synaptic stimuli
were delivered 50 ms apart. Scale bars: 10 ms, 20 pA.
(B) Summary graph illustrating that hemorrhaged rats (blue; n = 15)
had a reduced Pr compared to nonhemorrhaged naive rats (black;
n = 57), indicated by significant increases in PPR, failure rate, and
CV. *p < 0.05, **p < 0.01.
(C–E) Example of an injection site from animals microinjected with
prazosin, yohimbine, or vehicle into the PVN prior to hemorrhage.
The image shown is from case 5 of the yohimbine-injected group
(see Figure S1). (C) Low-power view (4X) of a transmitted light
image of a coronal slice of the PVN. (D) The injection site as indi-
cated by the red fluorescence of the Fluospheres. (E) Superim-
posed transmitted light and epifluorescence images. 3V, third
ventricle.
(F–H) Bar chart summaries of PPR, failure rate, and CV of eEPSCs
obtained from control naive slices (control; n = 57) and slices from
animals with yohimbine (10 nmol; n = 6), prazosin (10 nmol; n = 8),
or vehicle (n = 4) microinjected into the PVN prior to hemorrhage.
Since perturbations to body fluid homeostasis
sensed by peripheral receptors are relayed by norad-
renergic fibers to neurons in the hypothalamus (Buller
et al., 1999; Sawchenko and Swanson, 1981), we
hypothesized that LTD following hemorrhage was
mediated via activation of noradrenergic receptors.
To test this directly wemicroinjected subtype selective
adrenoceptor antagonists directly into the PVN prior to
hemorrhaging the rat (Figures 1C–1E). Figure S1 (avail-
able online) shows the distribution of the localized
injection sites for all subjects. Microinjection of the
a2-adrenoceptor antagonist yohimbine (10 nmol)
blocked the hemorrhage-mediated LTD (PPR 1.37 ± 0.14;
n = 6; p = 0.53; failure rate 0.04 ± 0.019; p = 0.92; CV 0.38 ±
0.049; p = 0.8; Figures 1F–1H). In contrast, microinjection of
the a1-adrenoceptor antagonist prazosin (10 nmol) into the
PVN failed to prevent LTD following hemorrhage (PPR 2.06 ±
0.43; n = 8; p = 0.02; failure rate 0.18 ± 0.08; p = 0.0009; CV
0.58 ± 0.12; p = 0.009). Vehicle injection had no effect on hemor-
rhage-induced LTD (PPR 1.95 ± 0.53; n = 4; p = 0.06; failure rate
0.12 ± 0.029; p = 0.04; CV 0.58 ± 0.027; p = 0.01). These results
demonstrate that hemorrhage results in LTD of glutamate
synapses that requires the activation of a2, but not a1, -adreno-
ceptors.
a2-Adrenoceptors and Endocannabinoids
Are Required for NA-Induced LTD
We next determined the mechanism through which a2-adreno-
ceptor activation induces LTD. In slices from naive, nonhemor-
rhaged rats bath application of NA (100 mM; 5 min) produced
a rapid depression of eEPSCs that relaxed to a less robust, but
LTD (LTDNA; eEPSC amplitude = 56.28% ± 6.67% of control;
n = 17; p < 0.0001; Figures 2A and 2B). Similar to LTD observed
following hemorrhage, LTDNA was also associated with an in-
crease in PPR (control 1.32 ± 0.10; post-NA 1.69 ± 0.17; n = 7;840 Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc.
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0.05; post-NA 0.47 ± 0.14; p = 0.02), and an increase in CV
(control 0.49 ± 0.09; post-NA 0.76 ± 0.14; p = 0.01).
To more carefully determine the adrenoceptor subtypes
necessary for LTDNA, we conducted a number of pharmacolog-
ical experiments. To test whether a1-adrenoceptors were
necessary for LTDNA, we bath-applied the selective a1-adreno-
ceptor agonist phenylephrine (PE; 50 mM). This failed to elicit
LTDNA (eEPSC amplitude = 122.78% ± 23.55% of control; n = 5;
p = 0.39; Figure 3F). In addition, the specific a1-adrenoceptor
antagonist prazosin (10 mM) failed to block induction of LTDNA
in response to bath application of NA (eEPSC amplitude =
68.76% ± 6.27% of control; n = 5; p = 0.04; Figure 3F), a result
consistent with the observed synaptic efficacy after in vivo
hemorrhage. Conversely, application of the a2-adrenoceptor-
subtype-selective antagonist yohimbine (20 mM) prior to and
during NA application prevented induction of LTDNA (eEPSC
Figure 2. Noradrenaline Induces Presynaptic LTD
(A) Representative single eEPSC recording illustrating LTD of evoked gluta-
mate release induced by NA (LTDNA). Traces show average paired-pulse
eEPSC responses in control (black) and 20 min after wash of NA (red) at the
times indicated. Scale bars: 10 ms, 20 pA.
(B) Data normalized and averaged from multiple neurons shows time course
and extent of LTDNA (n = 17).
(C) LTDNA was accompanied by an increase in PPR, failure rate, and CV.
*p < 0.05; n = 7.amplitude = 93.20% ± 5.36% of control; n = 7; p = 0.22; Figures
3A and 3F). If, however, yohimbine was applied after the induc-
tion of LTDNA, synapses remained depressed (eEPSC ampli-
tude = 59.23% ± 12.85%; n = 5; p = 0.04; Figure 3F). Application
of the a2-adrenoceptor agonist clonidine (50 mM) also caused a
long-lasting presynaptically expressed depression of evoked
glutamate release (eEPSC amplitude = 57.07% ± 7.65% of
control; n = 6; p = 0.009; PPR control 1.25 ± 0.23; PPR clonidine
2.70 ± 0.68; Figures 3B and 3F). This depression was not due to
slow unbinding of clonidine from the a2-adrenoceptor because
application of a yohimbine chaser after induction of LTDNA had
no effect (Figure 3B).
While the above observations strongly suggest that LTDNA
requires a2-adrenoceptors and is expressed presynaptically as
a reduction in glutamate Pr, they do not rule out the possibility
that a2-adrenoceptors are located on the postsynaptic cell and
when activated, produce a retrograde signal that depresses
glutamate release. Indeed, there is compelling evidence for
postsynaptic a2-adrenoceptors on MNCs in the PVN (Shirasaka
et al., 2007) as well as in other brain structures (Carr et al., 2007;
Cathala et al., 2002; Li and van den Pol, 2005; Liu and Alreja,
1998; Yamanaka et al., 2006), strengthening evidence that
activation of postsynaptic Gi/o-coupled receptors can promote
endocannabinoid (eCB) production through activation of phos-
pholipase D (PLD) (Basavarajappa, 2007; Di Marzo et al., 1994;
Jinsi-Parimoo and Deth, 1997; Senogles, 2000), and that CB1
receptors are located on nerve terminals in the hypothalamic
magnocellular neurosecretory system (Di et al., 2005a; Hirasawa
et al., 2004; Oliet et al., 2007). We directly tested for the involve-
ment of postsynaptic a2-adrenoceptors by conducting experi-
ments in which we included GDP-bs (1 mM) in our patch pipette
to block postsynaptic G protein signaling. Following perfusion
of the postsynaptic cell with GDP-bs for at least 10 min, applica-
tion of clonidine had no effect on eEPSCs amplitude (eEPSC
amplitude = 104.56% ± 8.94%; n = 8, p = 0.87; Figure 3C). This
indicates that a2-adrenoceptors are located on the postsynaptic
membrane. Since other Gi/o-coupled receptors act to depress
transmitter release through the recruitment of eCBs (Giuffrida
et al., 1999; Kreitzer and Malenka, 2007; Melis et al., 2004; Yin
and Lovinger, 2006), we conducted additional experiments in
which NA was bath applied in the presence of a CB1 receptor
antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichloro-
phenyl)-4-methly-1 H-pyrazole-3-carboximide (AM251; 1 mM).
The induction of LTDNA was prevented under these experimental
conditions (eEPSC amplitude = 116.34% ± 12.07% of control;
n = 8; p = 0.30; Figure 3D).
It is not clear whether eCB production following activation of
Gi/o-coupled receptors is Ca
2+ dependent. There is evidence
to support a direct, Ca2+-independent action of PLD (Jin et al.,
2007), but PLD also exhibits, if not a requirement for Ca2+, then
at least a reliance on Ca2+ (Kano et al., 2009; Ueda et al.,
2001). To determine whether a2-induced eCB production relies
on postsynaptic Ca2+, we loaded the postsynaptic cell with the
Ca2+ chelator BAPTA (10 mM) (Gerdeman et al., 2002; Robbe
et al., 2002). Under these conditions, NA failed to induce LTDNA
(eEPSC amplitude = 95.64% ± 14.88% of control; n = 12; p =
0.22; Figure 3E). These observations show that LTDNA requires
the activation of postsynaptic a2-adrenoceptors, which recruits,Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc. 841
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the presynaptic nerve terminal to decrease glutamate release.
LTD Is Accompanied by an a1-Mediated Functional
Downregulation of Group III mGluRs
In addition to activating a2-adrenoceptors, the release of NA
during hemorrhage will also stimulate a1-adrenoceptors. These
receptors are located on both the presynaptic nerve terminal and
neighboring astrocytes (Gordon and Bains, 2005). The activation
of presynaptic a1-adrenoceptors functionally inactivates high-
affinity group III mGluRs at synapses onto MNCs in the PVN
(Gordon and Bains, 2003). Since group III mGluRs gate meta-
plasticity in the hippocampus (Pelkey et al., 2005, 2008), we
hypothesized that NA released during hemorrhage or bath
applied in vitro to induce LTDNA may inactivate group III mGluRs
in the PVN, which would serve as a molecular switch for the
induction of activity-dependent synaptic potentiation.
To investigate the role of mGluRs at glutamatergic synapses
onto MNCs under basal conditions, we bath applied the group
III selective agonist L-2-amino-4-phosphonobutyric acid (L-AP4;
25 mM), which at this dose activates the high-affinity mGluR4 and
Figure 3. LTDNA Requires Postsynaptic a2-Adre-
noceptor Activation and Endocannabinoids
(A) Average normalized eEPSC amplitude of experiments
where NA was applied in the presence of the a2-adreno-
ceptor antagonist yohimbine (20 mM; n = 7). Inset scale
bars: 10 ms, 50 pA.
(B) Average eEPSC amplitude of experiments where cloni-
dine (50 mM; n = 6) was applied alone (open circles) and
where application of clonidine was chased with yohimbine
(n = 7; closed circles) at the time indicated. Inset scale
bars: 10 ms, 20 pA.
(C) Effects of clonidine on eEPSCs recorded with an intra-
cellular solution containing GDP-bs (1 mM; n = 8). Inset
scale bars: 10 ms, 50 pA.
(D) Average normalized eEPSC amplitude of experiments
where the CB1 receptor antagonist AM251 (1 mM) was
applied at least 5 min prior to NA (n = 8). Inset scale
bars: 10 ms, 200 pA.
(E) Summary of NA experiments where 10mMBAPTAwas
included in the patch pipette. BAPTA was allowed to
perfuse into the neuron for at least 15 min before NA
was applied (n = 12). Inset scale bars: 10 ms, 100 pA.
(F) Summary data showing the percent change in eEPSC
amplitude after 20 min wash of NA (100 mM; n = 17), phen-
ylephrine (PE; 50 mM; n = 5), NA in prazosin (praz + NA;
10 mM; n = 5), NA in yohimbine (yoh + NA; 20 mM; n = 7),
NA chased with yohimbine (NA + yoh chaser; n = 5),
clonidine (clon; 50 mM; n = 6), clonidine followed by
a yohimbine chaser (clon + yoh chaser; n = 7), clonidine
in cells patched with GDP-bs included in the intracellular
solution (GDP-bs + clon; n = 8), NA in the presence of
AM251 (AM251 + NA), and NA in cells patched with an
intracellular solution containing BAPTA (BAPTA + NA).
*p < 0.05; **p < 0.01.
8 subtypes. Following a stable baseline period
of recording (5–10 min), L-AP4 elicited a revers-
ible decrease in the amplitude of eEPSCs
(73.26% ± 7.48% of control; n = 9; p = 0.03;
Figure 4A). This was accompanied by increases in PPR (control
1.60 ± 0.14; L-AP4 2.04 ± 0.30; p = 0.04; Figure 4B), failure rate
(control 0.07 ± 0.04; L-AP4 0.13 ± 0.05; p = 0.11), and CV (control
0.34 ± 0.03; L-AP4 0.44 ± 0.05; p = 0.04), indicating a reduction
in the Pr of glutamate, consistent with group III mGluR inhibition
of quantal (action-potential-independent) glutamate release
(Oliet et al., 2001; Panatier et al., 2004; Schrader and Tasker,
1997). In addition, application of the selective group III mGluR
antagonist (RS)-a-methylserine-O-phosphate (MSOP; 100 mM)
resulted in an increase in the amplitude of eEPSCs (119.28% ±
10.95% of control; n = 7; p = 0.04; Figure S4) and a decrease
in the PPR (83.70% ± 5.77% of control, p = 0.03), suggesting
that mGluRs are tonically active at glutamate synapses onto
MNCs (Schrader and Tasker, 1997).
Since a1-adrenoceptor activation is coupled to a downregula-
tion of presynaptic group III mGluRs (Gordon and Bains, 2003),
we hypothesized that the effects of L-AP4 would be mitigated
following either hemorrhage or NA application. Consistent with
this idea, L-AP4 perfusion had no effect on eEPSCs in slices
from hemorrhaged rats (98.73% ± 4.68% of control amplitude;
n = 5; p = 0.95; PPR 102.48% ± 8.37%; p = 0.96; Figures 4C,842 Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc.
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animals that were microinjected with the a2-adrenoceptor
antagonist yohimbine into the PVN prior to hemorrhaging and
slicing (105.76% ± 4.66% control; n = 5; Figure 4D). Thus, the
in vivo yohimbine microinjection prevented induction of a2-adre-
noceptor-mediated LTD (Figures 1F–1H), but did not prevent the
concomitant a1-adrenoceptor-mediated inactivation of group III
mGluRs (Figures 4D, 4G, and 4H).
Toconfirmthe roleofNA in the inactivationofmGluRs,we tested
the effects of L-AP4 on evoked transmission at synapses that had
Figure 4. Hemorrhage and In Vitro NA Inacti-
vates Presynaptic Group III mGluRs
(A) Representative experiment showing that the group
III mGluR agonist (L-AP4, 25 mM) depresses eEPSCs
obtained fromMNCs in the PVN from a naive rat. Inset
shows average eEPSCs before (black) and after
(green) L-AP4. Scale bars: 10 ms, 50 pA.
(B) L-AP4 depressed eEPSCs presynaptically as indi-
cated by increases in PPR, failure rate, and CV (n = 9).
(C) Representative experiment illustrating that L-AP4
failed to depress eEPSCs in rats hemorrhaged
in vivo 30 min prior to slicing. Inset shows sample
eEPSCs from a hemorrhaged rat in control (blue) and
after L-AP4 (green). Scale bars: 5 ms, 50 pA.
(D) In slices obtained from rats that weremicroinjected
with yohimbine into the PVN in vivo prior to hemor-
rhaging, L-AP4was not effective in depressing evoked
glutamate release. Inset shows eEPSCs in control
(hem + yoh; microinjected with yohimbine and then
hemorrhaged) and after application of L-AP4 (green).
Scale bars: 20 ms, 50 pA.
(E) After induction of LTDNA subsequent application of
L-AP4 failed to depress glutamate synapses further.
Inset shows sample eEPSCs after LTDNA induction
(red) and subsequent application of L-AP4 (green).
Scale bars: 10 ms, 20 pA.
(F) Representative recording showing the effect of
L-AP4 application after clonidine. Group III mGluRs
are not inactivated following induction of LTD with
clonidine. Inset shows average eEPSCs after wash
of clonidine (orange) and following subsequent appli-
cation of L-AP4 (green). Scale bars: 20 ms, 20 pA.
(G and H) Summary bar graphs illustrating the effect of
L-AP4 on the amplitude of evoked glutamate release
(G) and PPR (H) in slices obtained from control naive
rats (con; black), after induction of LTDNA (NA; red;
n = 5), after clonidine LTD (clon; orange; n = 8), after
in vivo hemorrhage (hem; blue; n = 5), and after micro-
injection of yohimbine into the PVN followed by
hemorrhage (hem + yoh; n = 5). *p < 0.05.
undergone LTDNA. Under these conditions,
L-AP4 had no further effect on eEPSCs
(105.21% ± 7.88% of LTDNA values; n = 5;
p = 0.43; Figures 4E, 4G, and 4H), indicating
that after induction of LTDNA, high-affinity
group III mGluRs are inactivated/internalized.
To be certain that the lack of effect of L-AP4
onsynaptic transmission isdue to inactivation
of mGluRs and not a floor effect, we applied
L-AP4 to slices that had undergone cloni-
dine-mediated LTD. Here, mGluRs should still be active and in
these experiments, L-AP4 caused a depression of eEPSC ampli-
tude (77.50% ± 10.91% of LTD; n = 8; p = 0.04, Figure 4F). These
findings indicate that native group III mGluRs function to depress
glutamate releaseontoMNCs,but that the functionof these recep-
tors is compromised by hemorrhage-induced release of NA.
HFS Induces Potentiation following LTD
Since the inactivation/internalization of presynaptic group III
mGluRs in the hippocampus unmasks a metaplastic stateNeuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc. 843
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accompanied by an a1-adrenoceptor-mediated loss of mGluR
signaling, would provide the ideal conditions for activity-induced
plasticity. Consistent with this hypothesis, we observed a rapid
and persistent potentiation of eEPSCs in slices from hemor-
rhaged rats following HFS (3 3 100 Hz for 1 s, 10 s interval;
132.01% ± 8.29% of control 10–15 min post-HFS; n = 15; p =
0.0002; Figures 5A and 5B). During HFS the postsynaptic
membrane potential was held constant at a hyperpolarized
potential (Vhold = 80 mV). This potentiation was accompanied
by decreases in PPR (control 1.80 ± 0.19; post-HFS 1.49 ±
0.12; n = 15; p = 0.02), failure rate (control 0.14 ± 0.03; post-
HFS 0.03 ± 0.01; p = 0.005), and CV (control 0.54 ± 0.03; post-
HFS 0.45 ± 0.03; p = 0.0008; Figure 5C). The same HFS applied
to slices from control, nonhemorrhaged rats did not elicit
synaptic potentiation (amplitude 98.73% ± 3.14% of control
post-HFS, n = 11, p = 0.35; PPR 100.10% ± 3.47% of control
post-HFS, p = 0.77; ketamine-anesthetized controls and naive
rats pooled; Figures 5D and 5F). Taken together, these observa-
tions strongly suggest that an in vivo challenge to body fluid
homeostasis reduces Pr at glutamatergic synapses and leads
to a state where the synapses have the potential for undergoing
subsequent activity-dependent, presynaptic plasticity. Interest-
ingly, prazosin microinjection into the PVN prior to hemorrhage
prevented the synapses from undergoing activity-dependent
potentiation following HFS (104.32% ± 11.47% of control post-
Figure 5. Hemorrhage Unmasks Activity-
Dependent Plasticity
(A) Sample experiment showing HFS-induced (33
100 Hz for 1 s, 10 s interval) LTP in a rat hemor-
rhaged in vivo. Horizontal black lines indicate the
average eEPSC amplitude before and after HFS.
Inset shows eEPSCs from a hemorrhaged rat
before (blue) and after (purple) HFS. Scale bars:
10 ms, 20 pA.
(B) Summary of experiments illustrating the
response to HFS in hemorrhaged rats (n = 15).
(C) LTP in hemorrhaged rats was accompanied by
a reduced PPR, failure rate, and CV. *p < 0.05;
**p < 0.01.
(D) Summary of experiments showing that HFS
applied to naive slices failed to increase synaptic
strength (n = 11). Inset shows sample eEPSCs in
control and after HFS. Scale bars: 20 ms, 50 pA.
(E) Normalized group data showing the effects of
HFS on eEPSCs in slices from animals microin-
jected with prazosin in vivo prior to hemorrhage
(n = 5). Inset shows sample eEPSCs before (hem +
praz) and after HFS. Scale bars: 20 ms, 20 pA.
(F) Bar graph summarizing the group data of the
changes in eEPSC amplitude and PPR after HFS
in naive slices, following hemorrhage, and in
animals with prazosin microinjected into the PVN
prior to hemorrhage. *p < 0.05; **p < 0.01.
HFS; n = 5; p = 0.89; Figures 5E and
5F). Thus, acute hypovolemic hemor-
rhage not only causes an a2-adrenocep-
tor-mediated decrease in glutamatergic
synaptic efficacy, but also reveals an
a1-adrenoceptor-mediated unmasking of activity-dependent
presynaptic potentiation in response to HFS.
To determine if induction of LTDNA also unmasks a state
permissible for subsequent synaptic potentiation similar to that
observed following hemorrhage, we applied HFS to synapses
that had undergone LTDNA while holding the postsynaptic
membrane potential constant (Vhold = 80 mV). HFS resulted in
rapid repotentiation/de-depression of glutamatergic transmis-
sion that persisted for the duration of the recording (>20 min;
HFS post-LTDNA 96.91% ± 8.10% of pre-NA control values;
n = 11; p = 0.50; Figures 6A and 6B). At these synapses, the
potentiation was sufficient to completely reverse the changes
in PPR (control 1.23 ± 0.13; LTDNA 1.85 ± 0.10; p = 0.008;
post-HFS 1.25 ± 0.13; n = 5; p = 0.99), failure rate (control 0.08 ±
0.05; LTDNA 0.46 ± 0.11; p = 0.003; post-HFS 0.09 ± 0.04; p =
0.90), and CV (control 0.43 ± 0.06; LTDNA 0.72 ± 0.03; p =
0.01; post-HFS 0.46 ± 0.04; p = 0.99) observed during LTDNA
(Figure 6C). These results indicate that LTP also has a presyn-
aptic locus of expression and functionally represents the reverse
process of LTDNA. The potentiation observed following LTDNA
contrasts sharply with the absence of HFS-induced potentiation
in naive (NA untreated) slices (Figure 5D), indicating that this
plasticity depends upon previous activity of the network.
Since HFS potentiation, or metaplasticity, is observed when
synapses are depressed and mGluRs are inactive, we con-
ducted additional experiments to determine the necessity of844 Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc.
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that HFS-induced potentiation following LTDNA occurs because
low Pr at synapses increases the ‘‘ceiling’’ of the synapses and
makes them more amenable to potentiation in comparison to
synapses with higher Pr (as in control) (Bi and Poo, 1998). To
address this possibility, we carried out experiments in which Pr
was reduced in naive slices by perfusion of artificial cerebro-
spinal fluid (ACSF) containing high Mg2+ (3 mM) and low Ca2+
(1 mM). In high-Mg2+/low-Ca2+-treated slices, eEPSC amplitude
was reduced (35.29% ± 4.32% of control values) and PPR
increased (control 1.79 ± 0.27; high Mg2+/low Ca2+ 2.55 ±
0.56; n = 5). When HFS was applied, these synapses failed to
show potentiation (Figure S2A). Thus, we conclude that a reduc-
Figure 6. Noradrenaline-Mediated LTD Unmasks Metaplasticity
(A) Representative experiment showing HFS-induced LTP following LTDNA
induction. Sample traces are paired-pulse eEPSCs in control (black), during
LTDNA (red), and after HFS (purple). Scale bars: 10 ms, 50 pA.
(B) Summary of experiments showing the effect of HFS on eEPSC amplitude
after induction of LTDNA (closed black). The average time course of LTDNA in
the absence of HFS is replotted from Figure 2B for comparison (open gray).
(C) HFS restored PPR, failure rate, and CV to pre-LTDNA values. **p < 0.01.tion of Pr alone is not sufficient for metaplasticity at these
synapses. Next, to confirm that a1- and a2-adrenoceptors
specifically are necessary for metaplasticity, we applied another
G protein-coupled receptor agonist baclofen (30 mM), which acti-
vates GABAB receptors and lowers Pr at glutamate synapses
(Kombian et al., 1996). Baclofen depressed eEPSCs, but subse-
quent HFS had no effect on synaptic strength (Figure S2B). We
conducted additional experiments to determine the relative
contributions of LTD and the mGluRs to the metaplasticity. We
observed no potentiation in response to HFS at synapses that
had undergone prior LTD with clonidine (62.18% ± 3.50% of
control; n = 6; Figure S3A). Finally, we asked whether inhibition
of group III mGluRs was sufficient for activity-induced potentia-
tion of synapses. In the presence of MSOP, HFS induced a
pronounced posttetanic potentiation followed by a weak, longer
lasting potentiation of eEPSCs that was not as robust as the
potentiation observed after either LTDNA or hemorrhage (ampli-
tude 118.23% ± 6.86% of control; n = 10; p = 0.02; PPR
85.056% ± 6.203% of control; p = 0.05; Figure S4). On the other
hand, when BAPTA was included in the patch pipette to block
induction of LTDNA and synapses were subsequently stimulated
with HFS, no synaptic potentiation was observed (Figure S3B).
Collectively, these results confirm that both LTD and mGluR
inactivation are necessary for metaplasticity.
Finally, if the HFS-dependent synaptic potentiation is a reset-
ting of the synapses back to the naive state, then LTP should also
be accompanied by a recovery of function at high-affinity group
III mGluRs. To test this idea, we challenged synapses that were
potentiated by HFS (following LTDNA) with L-AP4. This caused
a reduction in eEPSC amplitude and an increase in PPR equiva-
lent to that observed in L-AP4-treated naive slices (73.05% ±
8.38% of post-HFS amplitude; n = 6; p = 0.04; Figure 7). These
results indicate that HFS returns the synapses to a state that is
functionally similar to the naive state (PPR return to control
values, mGluRs are active).
DISCUSSION
The data presented here demonstrate that glutamate synapses
in circuits regulating body fluid homeostasis are metaplastic.
This metaplasticity requires the functional inactivation of presyn-
aptic group III mGluRs and is evident both after the exposure of
naive slices to NA and in slices prepared from animals subjected
to an acute and precipitous loss of blood volume. In vitro appli-
cation of NA or in vivo hemorrhage results in a persistent reduc-
tion in evoked glutamate release onto MNCs in the PVN. The
reduction in Pr after NA (LTDNA) requires the activation of post-
synaptic a2-adrenoceptors, and the liberation of a retrograde
signal that targets presynaptic CB1 receptors. Finally, the inacti-
vation of mGluRs via a1-adrenoceptor stimulation primes the
synapses, allowing a rapid, persistent potentiation of synaptic
transmission in response to HFS of glutamatergic afferents.
This LTP is accompanied by a recovery of mGluR function. Our
results further support the hypothesis that mGluRs are critical
molecular switches for the induction of metaplasticity and
provide a link between the in vivo recruitment of neural circuits
and the ability of the synapses within this circuit to undergo
this powerful form of activity-dependent regulation.Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc. 845
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receptors are critical for the induction of LTDNA. Previous studies
in the hypothalamus have shown that eCBs can modulate
synaptic transmission transiently following either presynaptic
HFS or postsynaptic depolarization (Di et al., 2005a; Hirasawa
et al., 2004), via oxytocin receptor (Hirasawa et al., 2004; Oliet
et al., 2007) or glucocorticoid receptor (Di et al., 2005b, 2009;
Malcher-Lopes et al., 2006) stimulation. Our finding, however,
demonstrates that eCBs contribute to an enduring plasticity in
the hypothalamus and adds to the growing number of brain
structures wherein eCBs mediate long-term synaptic plasticity
(Chevaleyre et al., 2006; Lovinger, 2008). The activation of a2-
adrenoceptors is necessary for the induction of LTDNA and is
consistent with observations that activation of G protein-coupled
receptors recruits eCBs (Chevaleyre and Castillo, 2003; Kreitzer
and Malenka, 2005; Robbe et al., 2002; Ronesi and Lovinger,
2005; Sung et al., 2001). Interestingly, a2-adrenoceptors have
largely been assumed to be located on presynaptic nerve termi-
Figure 7. Functional Reactivation of Group III mGluR Signaling
after HFS
(A) Average time course showing that mGluR function recovers following post-
LTDNA HFS-induced LTP (n = 6). Inset shows sample eEPSCs in control, after
LTDNA induction (red), after HFS (purple), and after subsequent application of
L-AP4 (green). Scale bars: 5 ms, 20 pA.
(B and C) Summary graphs illustrating the percent change in eEPSC amplitude
and PPR in response to L-AP4 when it’s perfused on naive slices (green), on
slices after the induction of LTDNA (red; replotted from Figure 4), or on slices
after LTDNA induction with subsequent HFS (purple). Each bar represents an
individual experiment. *p < 0.05.846 Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc.nals, but aside from a few elegant demonstrations clearly
showing a role for presynaptic a2-adrenoceptors in synaptic
depression at glutamate synapses (Carey and Regehr, 2009;
Delaney et al., 2007), few studies have explicitly ruled out the
possible involvement of a retrograde messenger. There are
numerous observations in support of functional postsynaptic
a2-adrenoceptors (Carr et al., 2007; Cathala et al., 2002; Li
and van den Pol, 2005; Liu and Alreja, 1998; Shirasaka et al.,
2007; Yamanaka et al., 2006). Since activation of these Gi/o-
coupled receptors does not increase intracellular Ca2+, it is
thought unlikely that they would participate in the production of
retrograde signals. Recently, however, the D2-receptor, another
Gi/o-coupled receptor, has been shown to enhance eCB release
in the striatum and ventral tegmental area (Giuffrida et al., 1999;
Melis et al., 2004) and to be critical for eliciting eCB-LTD in the
striatum (Kreitzer and Malenka, 2005, 2007). In addition, these
receptors can couple to PLD, a key enzyme in the biosynthetic
pathway for eCBs (Basavarajappa, 2007). Although it’s not clear
if PLD activation is important for production of eCBs in MNCs,
the idea that PLD is at least partly reliant on and can be enhanced
by intracellular Ca2+ (Kano et al., 2009) is supported by our data
demonstrating that long-term a2-mediated inhibition is blocked
by inclusion of BAPTA in our patch pipette. Although the final
molecular steps mediating LTDNA remain to be determined,
there is compelling evidence in other systems that it may involve
the persistent inhibition of presynaptic P/Q-type or N-type Ca2+
channels (Brown et al., 2004; Hoffman and Lupica, 2000; Kreitzer
and Regehr, 2001) and/or interference with release machinery
(Chevaleyre et al., 2007; Gerdeman and Lovinger, 2001; Robbe
et al., 2001). Our experiments, however, argue against the latter
assertion because LTDNA of eEPSCs was accompanied by a
robust increase in the frequency of spontaneous EPSCs
(sEPSCs) (Gordon and Bains, 2003, 2005).
Consistent with our previous investigation showing that acti-
vation of a1-adrenergic receptors inactivated presynaptic group
III mGluRs (Gordon and Bains, 2003), L-AP4 treatment failed to
depress eEPSCs further after induction of LTDNA. This loss of
mGluR function is mediated by increased PKC activity (Gordon
and Bains, 2003; Macek et al., 1999), but it is not clear whether
mGluRs are internalized. Interestingly, internalization of mGluR7
is critical for the expression of metaplasticity at mossy fiber-
stratum lucidum interneuron (MF-SLIN) synapses in the hippo-
campus (Pelkey et al., 2005). The internalization of mGluR7 is
triggered by exposure to agonist (Pelkey et al., 2005, 2007),
whereas stable surface expression is dependent on PKC phos-
phorylation and receptor binding to the scaffolding protein
PICK1 (Suh et al., 2008). There are, however, two important
distinctions between metaplasticity at MF-SLIN synapses and
that described here. First, it appears that a different subtype of
group III mGluRs is involved. At glutamate synapses onto
MNCs, the high-affinity group III mGluRs (mGluR4 and 8) regu-
late neurotransmitter release, with little contribution from the
low-affinity mGluR7 subtype (Panatier et al., 2004) (although
see Schrader and Tasker, 1997). Our investigations using a
concentration of L-AP4 (25 mM) that targets only high-affinity
group III mGluRs are consistent with these observations.
Second, at MF-SLIN synapses, mGluR inactivation is dependent
on prolonged binding of agonist (glutamate) to the receptors. By
Neuron
Metaplasticity in Homeostatic Circuitscontrast, inactivation of mGluRs in our study depends on the
activation of a second, independent chemical signal, NA.
Whether mGluRs actually undergo internalization following NA
is unresolved. Recent work demonstrating internalization and
desensitization of mGluR4 following activation of PKC by phor-
bol ester treatment or Gaq-linked G protein-coupled receptor
activation (Mathiesen and Ramirez, 2006) offers support for the
internalization hypothesis in our scenario. Since the internaliza-
tion of mGluR7 is critical to the expression of metaplasticity at
MF-SLIN synapses (Pelkey et al., 2005), it seems plausible that
high-affinity group III mGluR internalization is also necessary
for metaplasticity at MNC glutamate synapses.
Based on our paired-pulse, CV, and failure analyses, both
LTDNA and HFS potentiation have a presynaptic locus of expres-
sion, indicating that potentiation functionally represents the
reverse process of LTD. Importantly, HFS not only restored
presynaptic release probability, but caused a gain of mGluR
function, suggesting that synapses return to a state that is func-
tionally identical to pre-LTDNA induction. This presynaptic poten-
tiation following HFS occurs in the absence of postsynaptic
depolarization and is fundamentally different from NMDA-
receptor-dependent plasticity described previously at glutamate
synapses onto MNCs (Panatier et al., 2006a, 2006b).
Our work adds to a growing metaplasticity field that highlights
the requirement for regulatory mechanisms to maintain synaptic
efficacywithin a functional dynamic range (Abraham, 2008; Clem
et al., 2008). Furthermore, it provides a critical proof that recent
demonstrations of presynaptic mGluRs as gatekeepers for a
novel form of metaplasticity (Pelkey et al., 2005, 2006, 2008)
can be extended to suggest that presynaptic mGluRs are also
a mechanism to alter synaptic strength in response to a physio-
logically relevant in vivo challenge. How might mGluR-mediated
metaplasticity in the hypothalamus contribute to restoration of
body fluid homeostasis? One possibility is that themetaplasticity
we describe here represents transitions of glutamate synapses
throughmultiple functional states that tightly regulate the activity
ofMNCs and therefore the appropriate release of hormones from
the posterior pituitary. In other words, internal homeostasis is
maintained by responding immediately and effectively to a chal-
lenge, operating at a new (transient) setpoint, and then resetting
the system. This includes an increase in Pr (Gordon and Bains,
2003, 2005) and an NA recruitment of astrocytes that promotes
AMPA receptor insertion (Gordon et al., 2005) that initially drives
MNCs, followed by an eCB-mediated persistent reduction in Pr
as the system begins to adapt to the challenge, and finally, an
activity-dependent resetting that is only possible if presynaptic
mGluRs are first inactivated.
EXPERIMENTAL PROCEDURES
Brain Slice Preparation
All experiments were performed according to protocols approved by the
University of Calgary Animal Care and Use Committee in accordance with
Canadian Council on Animal Care guidelines. Male Sprague-Dawley rats
(postnatal day 21 [P21]–P40) were anaesthetized using isoflurane and then
decapitated. The brain was quickly removed and placed in ice-cold slicing
solution containing (in mM) NaCl 87, KCl 2.5, NaHCO3 25, MgCl2 7, NaH2PO4
1.25, glucose 25, and sucrose 75 saturated with 95%/5% O2/CO2. The brain
was blocked, mounted on a vibrating slicer (Leica, Nussloch, Germany), andsubmerged in ice-cold slicing solution. Coronal slices (250 mm) of the hypothal-
amus containing the PVN were cut and transferred to an incubating chamber
containing ACSF at 32C for 45 min. The ACSF contained (in mM) NaCl 126,
KCl 2.5, NaHCO3 25, MgCl2 1.2, NaH2PO4 1.2, glucose 11, CaCl2 2.4, and as-
corbic acid 1 saturated with 95%/5% O2/CO2. Slices were maintained for a
minimum of 45 min at room temperature (21C–24C) before recording.
Electrophysiology
Hypothalamic slices were transferred to a recording chamber and superfused
with 32C–34CACSF at a flow rate of 1–2ml/min. Whole-cell recordings were
obtained from MNCs visualized with an AxioskopII FS Plus (Zeiss, Oberko-
chen, Germany) upright microscope fitted with infrared differential interference
contrast optics. MNCs were identified based on their morphology and well-
defined electrophysiological characteristics (Luther and Tasker, 2000).
Recordings were obtained using borosilicate glass microelectrodes (tip resis-
tance 3–5 MU) filled with a solution containing (in mM) K-gluconate 123, NaCl
8, EGTA 1, HEPES 16, MgCl2 2, K2ATP 0.3, and Na3GTP 0.3. For experiments
where BAPTA was included in the pipette solution, a minimum of 15 min was
allowed for intracellular diffusion. Recordings were accepted for analysis
if changes in access resistance were <15%. Cells were voltage clamped at
80 mV and the perfusate always contained picrotoxin (100 mM; Sigma-Al-
drich, St. Louis, MO) to block GABAA-mediated synaptic currents. Glutamater-
gic fibers were stimulated with an extracellular patch pipette filled with ACSF
that was always positioned lateral to the PVN in approximately the same loca-
tion. EPSCs were evoked at a rate of 0.1 Hz and paired-pulse responses were
obtained by applying a pair of synaptic stimuli 50 ms apart. Only synapses that
displayed a high degree of synchronous release 0–5 ms after the stimulation
were analyzed. For high HFS, afferents were stimulated at 100 Hz for 1 s,
repeated three times 10 s apart.
Signals were amplified using the Multiclamp 700B amplifier (Molecular
Devices, Union City, CA), low-pass filtered at 1 kHz, and digitized at 10 kHz
using the Digidata 1322 (Molecular Devices). Data were collected (pClamp
9.0, Molecular Devices) and stored on a computer for offline analysis. Evoked
currents were analyzed using Clampfit 9 (Molecular Devices). The amplitude of
the synaptic current was calculated from the baseline (current before evoked
response) to the peak of each evoked. For clarity, the stimulus artifacts have
been removed digitally from the traces depicted. PPRs (50 ms interstimulus
interval), CV, and failure rates weremeasured over 5min epochs of 30 eEPSCs
each. To exclude possible contributions from AMPA receptor insertion in
response to NA application (Gordon et al., 2005), recordings for the HFS
experiments in Figure 6 were performed with an intracellular solution contain-
ing EGTA (10 mM). This concentration of EGTA is sufficient to block postsyn-
aptic AMPA receptor insertion, but is not adequate to block the induction of
LTDNA. Results are expressed as means ± SEM. Significance was determined
using a Student’s t test or a one-way ANOVA with Tukey’s post hoc compar-
ison where appropriate with significance level of p < 0.05.
Hemorrhage
Rats were anaesthetized with ketamine-xylazine (100 mg/kg). Approximately
25% of blood volume (Lee and Blaufox, 1985) was removed by cardiac punc-
ture with a heparinized syringe over approximately 1 min. Brain slices were
prepared after either 2 or 30 min after hemorrhage, or an equal time anesthe-
tized without hemorrhage.
Microinjection of Chemicals into the PVN
Under ketamine-xylazine (100mg/kg) anesthesia, rats were microinjected with
prazosin (10 nmol), yohimbine (10 nmol), or vehicle (25% ACSF, 75% DMSO;
Blevins et al., 2002). Injections into the magnocellular subnucleus of the PVN
were performed using a stereotaxically fixed 10 ml Hamilton microsyringe.
The stereotaxic coordinates for the PVNwere as follows: 1.1–1.3 mmposterior
to Bregma, 1.6–1.7 mm from the midline at a 10 angle (to avoid bleeding from
the superior sagittal sinus), and 7.7–8.0 mm below the surface of the cortex
(Paxinos and Watson, 2005). A volume of 1 ml was delivered over 1–2 min
into the PVN to allow diffusion of the chemical. Each animal was injected unilat-
erally and either the right or left hemisphere was chosen randomly. Rats were
hemorrhaged approximately 2–4 min after the injections. Injection sites were
visually identified in hypothalamic slices by imaging FluoSpheres (0.1 mm,Neuron 62, 839–849, June 25, 2009 ª2009 Elsevier Inc. 847
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Metaplasticity in Homeostatic Circuitsred fluorescent; Invitrogen, Carlsbad, CA) that were included with the vehicle
at a dilution of 1:100. Injection sites were imaged using a Zeiss AxioskopII FS
Plus (4X objective lens) and epifluorescence imageswere captured using aRe-
tiga Exi camera (Q Imaging, Surrey, BC, Canada) with QCapture software.
SUPPLEMENTAL DATA
Supplemental data for this article include four Supplemental Figures andcanbe
found at http://www.cell.com/neuron/supplemental/S0896-6273(09)00430-9.
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